[1]
|
C. E. Elson, T. H. Maltzman, J. L. Boston, M. A. Tanner and M. N. Gould, “Anti-Carcinogenic Activity of d-Limonene during the Initiation and Promotion/Progression Stages of DMBA-Induced Rat Mammary Carcinogenesis,” Carcinogenesis, Vol. 9, No. 2, 1988, pp. 331-332. doi:10.1093/carcin/9.2.331
|
[2]
|
J. D. Haag, M. J. Lindstrom and M. N. Gould, “Limonene-Induced Regression of Mammary Carcinomas,” Cancer Research, Vol. 52, No. 14, 1992, pp. 4021-4026.
|
[3]
|
T. H. Maltzman, L. M. Hurt, C. E. Elson, M. A. Tanner and M. N. Gould, “The Prevention of Nitrosomethylurea-Induced Mammary Tumors by d-Limonene and Orange Oil,” Carcinogenesis, Vol. 10, No. 4, 1989, pp. 781-783. doi:10.1093/carcin/10.4.781
|
[4]
|
M. N. Gould, C. J. Moore, R. Zhang, B. Wang, W. S. Kennan and J. D. Haag, “Limonene Chemoprevention of Mammary Carcinoma Induction following Direct in Situ Transfer of V-Ha-Ras,” Cancer Research, Vol. 54, No. 13, 1994, pp. 3540-3543.
|
[5]
|
J. A. Elegbede, C. E. Elson, M. A. Tanner, A. Qureshi and M. N. Gould, “Regression of Rat Primary Mammary Tumors following Dietary d-Limonene,” Journal of the National Cancer Institute, Vol. 76, No. 2, 1986, pp. 323-325.
|
[6]
|
K. Zhao and J. Singh, “Mechanism(s) of in Vitro Percutaneous Absorption Enhancement of Tamoxifen by Enhancers,” Journal of Pharmaceutical Sciences, Vol. 89, No. 6, 2000, pp. 771-780. doi:10.1002/(SICI)1520-6017(200006)89:6<771::AID-JPS9>3.0.CO;2-Y
|
[7]
|
P. A. Cornwell, B. W. Barry, C. P. Stoddart and J. A. Bouwstra, “Wide-Angle X-Ray Diffraction of Human Stratum Corneum: Effects of Hydration and Terpene Enhancer Treatment,” Journal of Pharmacy and Pharmacology, Vol. 46, No. 12, 1994, pp. 938-950. doi:10.1111/j.2042-7158.1994.tb03248.x
|
[8]
|
K. Cal, S. Janicki and M. Sznitowska, “In Vitro Studies on Penetration of Terpenes from Matrix-Type Transdermal Systems through Human Skin,” International Journal of Pharmaceutics, Vol. 224, No. 1-2, 2001, pp. 81-88. doi:10.1016/S0378-5173(01)00744-X
|
[9]
|
J. R. Trevithick and K. P. Mitton, “Uptake of Vitamin E Succinate by the Skin, Conversion to Free Vitamin E, and Transport to Internal Organs,” Biochemistry & Molecular Biology International, Vol. 47, No. 3, 1999, pp. 509-518.
|
[10]
|
J. A. Schroeder, A. A. Masri, M. C. Adriance, J. C. Tessier, K. L. Kotlarczyk, M. C. Thompson and S. J. Gendler, “MUC1 Overexpression Results in Mammary Gland Tumorigenesis and Prolonged Alveolar Differentiation,” Oncogene, Vol. 23, No. 34, 2004, pp. 5739-5747. doi:10.1038/sj.onc.1207713
|
[11]
|
S. Wang, Y. Chen, Z. Gao, M. Xiong, Z. Zhong and L. Ye, “Gas Chromatographic-Mass Spectrometric Analysis of d-Limonene in Human Plasma,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 44, No. 5, 2007, pp. 1095-1099. doi:10.1016/j.jpba.2007.04.018
|
[12]
|
J. A. Miller, I. A. Hakim, C. Thomson, P. Thompson and H. H. Chow, “Determination of d-Limonene in Adipose Tissue by Gas Chromatography-Mass Spectrometry,” Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, Vol. 870, No. 1, 2008, pp. 68-73. doi:10.1016/j.jchromb.2008.06.002
|
[13]
|
M. Matura, A. Goossens, O. Bordalo, B. Garcia-Bravo, K. Magnusson, K. Wrangsjo and A. T. Karlberg, “Patch Testing with Oxidized R-(+)-Limonene and Its Hydroperoxide Fraction,” Contact Dermatitis, Vol. 49, No. 1, 2003, pp. 15-21. doi:10.1111/j.0105-1873.2003.00135.x
|
[14]
|
H. Pujol, J. Girault, P. Rouanet, S. Fournier, J. Grenier, J. Simony, J. B. Fourtillan and J. L. Pujol, “Phase I Study of Percutaneous 4-Hydroxy-Tamoxifen with Analyses of 4-Hydroxy-Tamoxifen Concentrations in Breast Cancer and Normal Breast Tissue,” Cancer Chemotherapy and Pharmacology, Vol. 36, No. 6, 1995, pp. 493-498. doi:10.1007/BF00685799
|
[15]
|
P. Rouanet, G. Linares-Cruz, F. Dravet, S. Poujol, S. Gourgou, J. Simony-Lafontaine, J. Grenier, A. Kramar, J. Girault, E. Le Nestour, et al., “Neoadjuvant Percutaneous 4-Hydroxytamoxifen Decreases Breast Tumoral Cell Proliferation: A Prospective Controlled Randomized Study Comparing Three Doses Of 4-Hydroxytamoxifen Gel to Oral Tamoxifen,” Journal of Clinical Oncology, Vol. 23, No. 13, 2005, pp. 2980-2987. doi:10.1200/JCO.2005.06.064
|
[16]
|
J. A. Miller, I. A. Hakim, W. M. Chew, P. A. Thompson, C. A. Thomson and H. H. Chow, “Adipose Tissue Accumulation of D-Limonene with the Consumption of a Lemonade Preparation Rich in D-Limonene Content.” Nutrition and Cancer, Vol. 6, No. 62, 2010, pp. 783-788. doi:10.1080/01635581003693066
|
[17]
|
P. L. Crowell, S. Lin, E. Vedejs and M. N. Gould, “Identification of Metabolites of the Antitumor Agent d-Limonene Capable of Inhibiting Protein Isoprenylation and Cell Growth,” Cancer Chemotherapy and Pharmacology, Vol. 31, No. 3, 1992, pp. 205-212. doi:10.1007/BF00685549
|
[18]
|
M. Magnano, S. Silvani, C. Vincenzi, M. Nino and A. Tosti, “Contact allergens and Irritants in Household Washing and Cleaning Products,” Contact Dermatitis, Vol. 61, No. 6, 2009, pp. 337-341. doi:10.1111/j.1600-0536.2009.01647.x
|
[19]
|
Association FaEM, “d-Limonene Monograph,” No. 1991, pp. 1-4.
|
[20]
|
Geneva WHO, International Programme on Chemical Safety (No. 0918), “International Chemical Safety Card-d-Limonene.” 1993.
|
[21]
|
A. S. Malik, O. Boyko, N. Atkar and W. F. Young, “A Comparative Study of MR Imaging Profile of Titanium Pedicle Screws,” Acta Radiologica, Vol. 42, No. 3, 2001, pp. 291-293. doi:10.1080/028418501127346846
|